Drugs & Aging

Adis, Springer Healthcare

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Drugs & Aging is a journal published by Adis, Springer Healthcare in New Zealand. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Adis, Springer Healthcare
ISSN
1170-229X · 1179-1969
Country
New Zealand
Access
Not open access / not declared
Declared publication charge
4,390 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1991-01-01
  • PUBMED · 2010-01-01
Indexing
MEDLINE · PUBMED
APC
4,390 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
127 days received→accepted — computed from PubMed (n=93)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

3083

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

134

i10-index

2122

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
89%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Drugs & ageingDrugs and aging
Source type
journal
NLM unique ID (PubMed)
9102074
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Dementia and Cognitive Impairment Research
  • Medication Adherence and Compliance
  • Medication Adherence and Compliance
  • Dementia and Cognitive Impairment Research
  • Dementia and Cognitive Impairment Research
Show all subjects (75)
  • Pharmacy and Medical Practices
  • Pain Management and Opioid Use
  • Blood Pressure and Hypertension Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Blood Pressure and Hypertension Studies
  • Blood Pressure and Hypertension Studies
  • Frailty in Older Adults
  • Alzheimer's disease research and treatments
  • Pharmaceutical studies and practices
  • Heart Failure Treatment and Management
  • Heart Failure Treatment and Management
  • Geriatric Care and Nursing Homes
  • Urinary Bladder and Prostate Research
  • Cholinesterase and Neurodegenerative Diseases
  • Frailty in Older Adults
  • Frailty in Older Adults
  • Bone health and osteoporosis research
  • Pain Management and Opioid Use
  • Pain Management and Opioid Use
  • Intensive Care Unit Cognitive Disorders
  • Intensive Care Unit Cognitive Disorders
  • Pharmacovigilance and Adverse Drug Reactions
  • Atrial Fibrillation Management and Outcomes
  • Medication Adherence and Compliance
  • Chronic Disease Management Strategies
  • Menopause: Health Impacts and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Parkinson's Disease Mechanisms and Treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Bone health and osteoporosis research
  • Bone health and osteoporosis research
  • Urinary Bladder and Prostate Research
  • Urinary Bladder and Prostate Research
  • Schizophrenia research and treatment
  • Pharmacovigilance and Adverse Drug Reactions
  • Schizophrenia research and treatment
  • Heart Failure Treatment and Management
  • Pharmacovigilance and Adverse Drug Reactions
  • Balance, Gait, and Falls Prevention
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Diabetes Treatment and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Intensive Care Unit Cognitive Disorders
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Alzheimer's disease research and treatments
  • Alzheimer's disease research and treatments
  • Treatment of Major Depression
  • Geriatric Care and Nursing Homes
  • Rheumatoid Arthritis Research and Therapies
  • Geriatric Care and Nursing Homes
  • Bone health and treatments
  • Inflammatory mediators and NSAID effects
  • Inflammatory mediators and NSAID effects
  • Treatment of Major Depression
  • Treatment of Major Depression
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Pharmacological Effects and Toxicity Studies
  • Pharmacological Effects and Toxicity Studies
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: